Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novel Lipid Management Therapies In High-Risk Patients - A Paradigm Shift
Seeking Alpha
Thursday, August 23, 2012 - 9:55am
tags:
Aegerion, Isis Pharmaceuticals, LDL cholesterol, lomitapide, mipomersen
3 Reasons to Sell: VIVUS
Motley Fool
Thursday, August 23, 2012 - 9:54am
tags:
Vivus, patents, Qsymia
Pfizer's Latest Drug Could Result In Significant Growth If Approved
Seeking Alpha
Thursday, August 23, 2012 - 9:53am
tags:
Pfizer, Abbott Laboratories, tofacitinib, rheumatoid arthritis
Merck Gives InSite A Gift; What Does It Mean?
Seeking Alpha
Thursday, August 23, 2012 - 9:52am
tags:
Merck, InSite Vision
Pfizer Asks End To Fen-Phen Suits Linked To Lung Ailment
Bloomberg
Thursday, August 23, 2012 - 9:42am
tags:
Pfizer, Fen-Phen, Wyeth, primary pulmonary hypertension, PPH
Latest Drug Sales Data: Loss of Patent Protection Has Significant Effect, According to Drugs.com
Pharma Live
Wednesday, August 22, 2012 - 11:54am
tags:
drug sales, patents, generics
Big BioPharma Stock Buybacks: Are There Better Alternatives?
Forbes
Wednesday, August 22, 2012 - 11:44am
tags:
stock buybacks
Supreme Court to hear Novartis patent case from Sept 11
Reuters
Wednesday, August 22, 2012 - 11:42am
tags:
patents, Novartis, Gleevec, Supreme Court, India
Ranbaxy drops some applications filed with FDA
Marketwatch
Wednesday, August 22, 2012 - 11:38am
tags:
FDA, Ranbaxy, India
Roche winning on Perjeta supply, but running short of Boniva
InPharm
Wednesday, August 22, 2012 - 11:37am
tags:
Perjeta, Boniva, Roche
Cipla, Aspen eye joint excursion in Australia
Fierce Pharma
Wednesday, August 22, 2012 - 11:36am
tags:
Aspen, Cipla, Australia, GSK
Former Abbott Rep Files TriCor Off-Label Lawsuit
Pharmalot
Wednesday, August 22, 2012 - 11:16am
tags:
Abbott Laboratories, TriCor, off-label, whistleblower lawsuits
New Intermezzo Patent And Orange Book Listing Are Major Positives For Transcept Pharma
Yahoo/Reuters
Wednesday, August 22, 2012 - 11:13am
tags:
Intermezzo, Transcept
Peregrine: Bavi Results Are Overhyped And Inconclusive
Seeking Alpha
Wednesday, August 22, 2012 - 11:12am
tags:
bavituximab, Peregrine Pharmaceuticals, cancer
Big Pharmas: New Drugs Will Make You Money
Seeking Alpha
Wednesday, August 22, 2012 - 11:10am
tags:
Abbott Laboratories, JNJ, Bristol-Myers Squibb, Merck, Eli Lilly, Healon EndoCoat, Erbitux, suvorexant, Xarelto
Impax optimistic about successful resolution of warning letter, says Leerink
Yahoo/Fly on the Wall
Wednesday, August 22, 2012 - 11:08am
tags:
Impax, warnings
Hope for Eli Lilly Alzheimer's Drug Wanes
Minyanville
Wednesday, August 22, 2012 - 11:05am
tags:
Eli Lilly, Alzheimer's disease, solanezumab
MannKind and Sirius Are Heating Up
Motley Fool
Wednesday, August 22, 2012 - 11:04am
tags:
MannKind
Amgen Doing Fine Despite Challenges
Investors.com
Wednesday, August 22, 2012 - 11:04am
tags:
Amgen
Co-pay coupons lifted Lipitor. Can they defend Diovan?
Fierce Pharma
Tuesday, August 21, 2012 - 5:10pm
tags:
co-pay coupons, Lipitor, Pfizer, Diovan, Novartis, Plavix, Bristol-Myers Squibb

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.